VACCINEX, INC.·4

Feb 8, 4:34 PM ET

Royer Scott E. 4

4 · VACCINEX, INC. · Filed Feb 8, 2019

Insider Transaction Report

Form 4
Period: 2019-02-06
Royer Scott E.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2019-02-07$5.05/sh+1,725$8,7113,999 total
  • Purchase

    Common Stock

    2019-02-06$4.57/sh+275$1,2572,274 total
Holdings
  • Stock option (right to buy)

    Exercise: $13.60Exp: 2028-02-21Common Stock (25,000 underlying)
    25,000
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.75 to $5.17 per share, inclusive. Mr. Royer undertakes to provide to Vaccinex, Inc., any securityholder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
  • [F2]This option initially vests in quarterly installments of 1,526 shares for each of four quarters beginning on May 21, 2018. The remainder vests in three equal annual installments beginning February 21, 2020.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT